mycoplasma

Tylosin tartrate, a macrolide antibiotic, is approved for the control of mycoplasmosis in poultry.

Marbofloxacin (Zeniquin) is an effective, broad-spectrum antibiotic of bacterial, which inhibits DNA replication.

Tylosin (Tylosine) is a macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans.

Danofloxacin (Danofloxacin free base) is a fluoroquinolone antibiotic used in veterinary medicine.

Tetracycline is an orally active broad-spectrum antibiotic that exhibits inhibitory activity against various Gram-positive and Gram-negative bacteria, as well as Chlamydia, Mycoplasma, and Rickettsia. It is commonly used in anti-infection research and can also be used to induce tumor regression based on BCR-ABL gene silencing.

Chlortetracycline Hydrochloride is a tetracycline with broad-spectrum antibacterial and antiprotozoal activity. Chlortetracycline hydrochloride (Isphamycin) is bacteriostatic and inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, thereby preventing the addition of amino acids to the growing peptide chain. This tetracycline is active against a wide range of gram-positive and gram-negative organisms, spirochetes, rickettsial species, certain protozoa and Mycoplasma and Chlamydia organisms.

Enrofloxacin (BAY-Vp2674) is a veterinary antibacterial agent, used in poultry.

Nystatin (Fungicidin) is a topical and oral antifungal agent with activity against many species of yeast and candida albicans, which is used largely to treat skin and oropharyngeal candidiasis.

Leu-Leu-OH is a derivative dipeptide of leucine that can be used to study the function of the double leucine motif, is present as a metabolite in the human body, and is also detected in certain bacteria (e.g. Mycoplasma genitalium).

Pam2Cys is an L-cysteine thioether where the hydrogen of the thiol group is replaced by a 2,3-di(palmitoyloxy)propyl group. It acts as a Toll-like receptor 2 agonist and a metabolite of Mycoplasma genitalium. Additionally, Pam2Cys is associated with the function of palmitoleic acid.

2'-Amino-2'-deoxyadenosine (9-(2-Amino-2-deoxypentofuranosyl)-9H-purin-6-amine) is a nucleoside antibiotic that effectively inhibits various Mycoplasma strains.

Laidlomycin, a polyether, polycyclic, monocarboxylic acid, possesses inhibitory activity against various Mycoplasma species, especially Acholeplasma laidlawii.

Mirosamicin is a macrolide antibiotic, it has antimicrobial effect against gram-positive bacteria, some gram-negative bacteria and mycoplasma.

Antibacterial agent 90 (6n) is a pleuromutilin derivative with antibacterial activity against Gram-positive pathogens (GPPs) and Mycoplasma pneumoniae.

Enrofloxacin hydrochloride is an effective antibiotic with an MIC90 of 0.312 μg mL for Mycoplasma bovis.

Enrofloxacin-d5 is a deuterium marker for Enrofloxacin and can be used in isotope tracer experiments.Enrofloxacin (BAY-Vp2674) is an antibiotic that acts against Mycoplasma bovis and has a MIC90 of 0.312 μg/mL.

Marbofloxacin hydrochloride, a third-generation fluoroquinolone and orally active antimicrobial agent, exhibits broad-spectrum bactericidal activity and high efficacy. It is utilized in the research of infections caused by both Gram-positive and Gram-negative bacteria, as well as Mycoplasma.

Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is a potent antibiotic with a minimum inhibitory concentration (MIC 90) of 0.312 μg mL against Mycoplasma bovis, and it also exhibits inhibitory activity against the vaccinia virus (VV).

Maximin S4, an antimicrobial peptide sourced from the toad Bombina maxima, exhibits antibacterial activity against mycoplasma [1].

Neoviridogrisein I is utilized to combat Gram-positive bacteria and mycoplasma.

6-O-Demethyl-5-deoxyfusarubin possesses antifungal and mycoplasma-inhibiting properties.

Chimeramycin A exhibits activity against Gram-positive bacteria and mycoplasma.

Cirramycin A1 exhibits activity against both Gram-positive and Gram-negative bacteria and is also effective against various mycoplasmas. Its minimum inhibitory concentration against Mycoplasma pneumoniae is 0.001 μg/mL.

Resorcinomycin A is an antibiotic with potent antimycobacterial activity and relatively weaker activity against mycoplasma.